Cl. Nutt et al., O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN TUMORS AND CELLS OF THE OLIGODENDROCYTE LINEAGE, Canadian journal of neurological sciences, 22(2), 1995, pp. 111-115
Background: Oligodendrogliomas respond to nitrosourea-based chemothera
py and are induced in rats following transplacental exposure to ethyln
itrosourea, observations suggesting that neoplastic and normal cells o
f the oligodendrocyte lineage are ''sensitive'' to nitrosoureas. Nitro
soureas alkylate DNA at O-6-guanine with repair mediated by O-6-methyl
guanine-DNA methyltransferase (MGMT). The cytotoxic and carcinogenic p
roperties of the nitrosoureas appear related to MGMT activity. Methods
: To explore why oligodendrogliomas respond to chemotherapy, we measur
ed MGMT activity in five chemosensitive human oligodendrogliomas and i
n rat oligodendrocyte lineage cells. We also measured MGMT activity in
rat astrocytes and compared the cytotoxic effects of carmustine (BCNU
) on oligodendrocyte lineage cells and astrocytes. Results: Low levels
of MGMT activity were found in five of five human oligodendrogliomas.
Cultures of neonatal rat glia enriched for oligodendrocyte lineage ce
lls also had low levels of MGMT activity, approximately one-third that
found in astrocytes (p < 0.02), and oligodendrocyte lineage cells wer
e more sensitive to BCNU than astrocytes. Conclusions: Low MGMT activi
ty may contribute to the chemosensitivity of some human oligodendrogli
omas and rat oligodendrocyte lineage cells also have low levels. If dr
ug resistance mechanisms in tumors reflect the biochemical properties
of their cells of origin, then normal glia may serve as a laboratory s
ubstitute for human glioma.